Stamford, CT -- (SBWIRE) -- 01/17/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Netlist, Inc. (NASDAQ:NLST), Delcath Systems, Inc. (NASDAQ:DCTH), Codexis, Inc. (NASDAQ:CDXS), Prosensa Holding NV (NASDAQ:RNA)
Netlist, Inc. (NASDAQ:NLST) opened the session at $0.90, trading in a range of $0.88 - $1.37. The stock showed a positive performance of +49.22% in the last trading session from its previous close of $0.8712and closed at $1.30. The stock traded on a volume of 3.26 million shares and the average volume of the stock remained 144,366 shares. Netlist, Inc. (Netlist) designs, manufactures and sells memory subsystems for datacenter server and high-performance computing and communications markets. Netlist’s memory subsystems consist of combinations of dynamic random access memory integrated circuits (DRAM ICs or DRAM), NAND flash memory (NAND), application-specific integrated circuits (ASICs) and other components assembled on printed circuit boards (PCBs).
For How Long NLST will Fight for Profitability? Read This Trend Analysis report
Delcath Systems, Inc. (NASDAQ:DCTH) traded 27.83 million shares in the last business day while the average volume of the stock remained 4.41 million shares. The stock showed a positive movement of +30.96% to end at $0.390. The 52 week range of the stock remained $0.22 - $2.19. Delcath Systems, Inc. (Delcath) is a development-stage, specialty pharmaceutical and medical device company, focused on oncology, initially cancers in the liver. Delcath focuses on the development and clinical study of the Delcath chemosaturation system.
Has DCTH Found The Bottom And Ready To Gain Momentum? Find Out Here
Codexis, Inc. (NASDAQ:CDXS) reported 2.03 million shares were exchanged during the last trade, while the average volume is about 156,261 shares. The stock escalated +26.53% and finished the day at $1.86. The beta of the stock is recorded at 2.01. Codexis, Inc. provides biocatalyst and fermentation processes and products. The Company provides its customers research and development services, biocatalysts and fermentation strains, synthetic and natural products. It is a subsidiary of publicly-traded Maxygen. Codexis uses the Molecular Breeding platform to develop enzymes and fermentation strains. These biocatalysts are designed for specific commercial applications, and various manufacturing processes.
For How Long CDXS’s Gloss will Attract Investors? Find out via this report
Prosensa Holding NV (NASDAQ:RNA) shares rose, +24.37 percent from its previous close of $5.54 to close at $6.89. Traded with volume of 6.39 million shares in the prior session and the average volume of the stock remained 310,610 shares. Prosensa Holding N.V., formerly Prosensa Holding B.V., is a biotechnology company engaged in the discovery and development of ribonucleic acid-modulating (RNA)-modulating, therapeutics for the treatment of genetic disorders.
Why Should Investors Buy RNA After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)